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Abstract
Previous evidence suggests a circadian modulation of drug-seeking behavior and responsiveness to drugs of abuse. To identify
potential mechanisms for rhythmicity in reward, a marker of neural activation (cFos) was examined across the day in the meso-
limbic reward system. Rats were perfused at six times during the day [zeitgeber times (ZTs): 2, 6, 10, 14, 18, and 22], and brains
were analysed for cFos and tyrosine hydroxylase (TH)-immunoreactive (IR) cells. Rhythmic expression of cFos was observed in
the nucleus accumbens (NAc) core and shell, in the medial prefrontal cortex (mPFC), and in TH-IR and non-TH-IR cells in the
ventral tegmental area (VTA), with peak expression during the late night and nadirs during the late day. No significant rhythmicity
was observed in the basolateral amgydala or the dentate gyrus. As the mPFC provides excitatory input to both the NAc and VTA,
this region was hypothesised to be a key mediator of rhythmic neural activation in the mesolimbic system. Hence, the effects of
excitotoxic mPFC lesions on diurnal rhythms in cFos immunoreactivity at previously observed peak (ZT18) and nadir (ZT10) times
were examined in the NAc and VTA. mPFC lesions encompassing the prelimbic and infralimbic subregions attenuated peak cFos
immunoreactivity in the NAc, eliminating the diurnal rhythm, but had no effect on VTA rhythms. These results suggest that rhyth-
mic neural activation in the mesolimbic system may contribute to diurnal rhythms in reward-related behaviors, and indicate that
the mPFC plays a critical role in mediating rhythmic neural activation in the NAc.
Introduction
Rewarding behaviors are largely mediated by the mesolimbic system
(Wise, 2004; Frohmader et al., 2010a), composed of the ventral teg-
mental area (VTA), nucleus accumbens (NAc), medial prefrontal
cortex (mPFC), amygdala, and other regions (Spanagel & Weiss,
1999; Ikemoto, 2007). Mesolimbic brain areas are activated during
natural reward behaviors (Noel & Wise, 1995; Martel & Fantino,
1996), including sexual behavior (Pfaus et al., 1990; Balfour et al.,
2004; Frohmader et al., 2010b; Pitchers et al., 2010), aggression
(Wolf et al., 2004), and maternal behavior (Champagne et al., 2004;
Numan et al., 2010); and in response to conditioned cues predicting
natural rewards (Balfour et al., 2004), and drugs of abuse (Di Chi-
ara & Imperato, 1988; Thomas et al., 2008). A growing body of
work has revealed that many of the behavioral responses to reward-
ing stimuli vary substantially over the course of a day. Conditioned
place preference, locomotor activation and sensitisation in response
to psychostimulants (Abarca et al., 2002; Kurtuncu et al., 2004;
Webb et al., 2009) and natural rewards (Webb et al., 2009) depend
signiﬁcantly on the time of day. The mechanisms responsible for
these diurnal rhythms in motivation and reward remain to be fully
elucidated, but there is evidence for involvement of the mesolimbic
system, and particularly for the neurotransmitter dopamine. Markers
of dopaminergic activity vary by time of day in the VTA and NAc,
including the expression of tyrosine hydroxylase (TH), the rate-lim-
iting enzyme in dopamine synthesis (Sleipness et al., 2007; Webb
et al., 2009), dopamine transporters (Sleipness et al., 2007), and
monoamine oxidase (Hampp et al., 2008).
Here, we characterised diurnal ﬂuctuations in neural activation
throughout the mesocorticolimbic system, using cFos protein expres-
sion as the marker. The use of cFos to elucidate diurnal rhythms in
neural activation is well documented for brain areas involved in
sleep and wakefulness (Pompeiano et al., 1995; Bentivogolio,
1999), including activation of the orexin–hypocretin system (Esta-
brooke et al., 2001; Martinez et al., 2002). Moreover, investigation
of cFos protein expression during sleep and awake states provided
support for diurnal rhythms in neural activation in the mesolimbic
system (Pompeiano et al., 1994). However, a comprehensive charac-
terisation of neural activation in the mesolimbic system across the
day has yet to be conducted.
We also tested the hypothesis that the mPFC plays a critical role
in mediating the daily rhythms in neural activation in the mesolim-
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bic system. The mPFC provides a major source of glutamatergic
inputs to the VTA and NAc (Carr & Sesack, 1999, 2000; Balfour
et al., 2006; Omelchenko & Sesack, 2007), and glutamate receptor
activation has been implicated in the induction of cFos expression
(Xia et al., 1996; Rossetti et al., 1998; Vanhoutte et al., 1999;
Dominguez et al., 2007). Therefore, the mPFC is a potential candi-
date for regulating diurnal rhythms in neural activation in its target
areas.
Materials and methods
Animals
Young adult male Sprague-Dawley rats (300–350 g; Charles River
Laboratories, Quebec, Canada) were pair-housed in standard rat
housing cages with ad libitum food and water. The rats were
placed under a 12 : 12-h light/dark cycle (~350 lux light/0 lux
dark), and were allowed to acclimatise and entrain to the light/
dark cycle for 2 weeks prior to tissue collection or surgery. All
experiments were approved by the University of Western Ontario
Animal Care Committee and the University Committee on Use
and Care of Animals at the University of Michigan, and were
performed in compliance with the guidelines of the Canadian
Council on Animal Care and the United States National Institutes
of Health.
Tissue collection
At six different zeitgeber times (ZTs) (ZT2, ZT6, ZT10, ZT14,
ZT18, and ZT22, where ZT12 corresponds to lights off, by conven-
tion), rats (n = 6–8 per time point) were deeply anesthetised with
intraperitoneal sodium pentobarbital (270 mg/kg) and perfused tran-
scardially with 50 mL of saline followed by 500 mL of 4% parafor-
maldehyde in 0.1 M phosphate buffer (PB). Brains were removed,
post-ﬁxed for 1 h, and stored in 20% sucrose in 0.1 M PB with
0.01% sodium azide at 4 °C until sectioning. For time points coin-
ciding with the dark phase, tissue collection was performed under
dim red light (~1 lux). Brains were sectioned with a freezing micro-
tome into four parallel series of 35-lm coronal sections, and stored
in cryopreservative (Watson et al., 1986) at 20 °C until immuno-
histochemical processing.
Immunohistochemistry
All incubations and rinses were performed at room temperature
on free-ﬂoating tissue with gentle agitation. Following each incu-
bation, sections were rinsed thoroughly in phosphate-buffered sal-
ine (PBS) (0.1 M, pH 7.4). One series of brain sections from all
experimental animals were stained simultaneously. The tissue was
ﬁrst incubated for 10 min in 1% H2O2 in 0.1 M PBS and for 1 h
in incubation solution [0.1% bovine serum albumin and 0.4% Tri-
ton X-100 (Fisher Scientiﬁc, Ottawa, Ontario, Canada) in PBS].
Next, the tissue was incubated with a rabbit polyclonal antibody
speciﬁcally recognising cFos (1 : 7500 in incubation solution;
17 h; SC-52; Santa Cruz Biotechnology, Santa Cruz, CA, USA)
followed by biotinylated donkey anti-rabbit IgG (1 : 500 in incu-
bation solution; 1 h; Jackson Immunoresearch Laboratories, West
Grove, PA, USA) and avidin–biotin–horseradish peroxidase com-
plex (ABC) (1 : 1000 in PBS; 1 h; ABC Elite Kit; Vector Labo-
ratories, Burlingame, CA, USA). Antibody binding was visualised
with diaminobenzidene (DAB) (Sigma-Aldrich, St Louis, MO,
USA) solution (0.01% DAB, 0.012% H2O2 in 0.1 M PB) contain-
ing 0.08% nickel sulfate for 10 min, resulting in a black reaction
product. Sections were then washed with H2O2 (1% in PBS;
10 min), and incubated with a mouse monoclonal antibody
against TH (1 : 400 000 in incubation solution; 17 h; Chemicon
International, Temecula, CA, USA), a biotinylated donkey anti-
mouse IgG (1 : 500 in PBS; 1 h; Jackson Immunoresearch), and
ABC (1 : 1000 in PBS; 1 h). TH immunoreactivity was visualised
with DAB (0.01% DAB and 0.012% H2O2 in PB (0.1 M;
10 min), resulting in a brown reaction product (Fig. 2). Finally,
sections were thoroughly rinsed in PB, mounted on plus-charged
slides (Fisher Scientiﬁc), dehydrated in alcohol, cleared with Citri-
solv (Fisher Scientiﬁc), and coverslipped with di-N-butyl phthalate
in xylene (Electron Microscopy Sciences, Fort Washington, PA,
USA). The cFos antibody has been extensively validated, and
results in a single band at the appropriate mass on western blot.
Cell counting and analysis
cFos-immunoreactive (IR) neurons in reward-related brain areas
were counted in one or two sections per rat, with standard areas
of analysis determined in accordance with previously deﬁned land-
marks (Swanson, 1998) (Fig. 1). The areas were as follows: the
NAc core (400 9 600 lm) and shell (400 9 600 lm); the anterior
cingulate area (ACA) (400 9 600 lm), the infralimbic (IL)
(400 9 600 lm) and the prelimbic (PL) (400 9 600 lm) regions
of the mPFC; the central amygdala (CeA) 400 9 400 lm) and ba-
solateral amygdala (BLA) (600 9 400 lm); and the dentate gyrus
(DG) (1800 9 1200 lm). For each rat, counts were averaged to
derive the mean number of cFos cells per unilateral structure. In
the VTA (900 9 600 lm), cFos-IR, TH-IR and dual-labeled neu-
rons were counted in two sections at the rostral–middle level (Bal-
four et al., 2004). More caudal levels of the VTA were not
included, as no cFos expression was noted at any time points.
Counts of cFos-IR cells in the suprachiasmatic nucleus (SCN)
(400 9 400 lm) in two sections were performed as a positive
control for circadian activation rhythms (Schwartz et al., 2000).
Cell counts were carried out by two observers blinded to the
experimental groups, using a Leica DMR microscope (Leica
Microsystems,Wetzlar, Germany) with a camera lucida drawing
tube.
Statistical analysis
One-way ANOVA followed by Newman–Keuls comparisons, Kruskal–
Wallis ANOVA followed by Dunn’s comparisons or independent
t-tests were utilised, where appropriate, to examine time-of-day
effects. To conﬁrm diurnal rhythmicity, data were also analysed with
CIRCWAVE software (v. 1.4, courtesy of R. Hut; http://www.
euclock.org). CIRCWAVE uses harmonic regression to ﬁt a sinusoidal
curve to the data and to test its signiﬁcance against a ﬁtted horizon-
tal line.
mPFC lesion surgery and verification
Rats were anesthetised with intraperitoneal ketamine (87 mg/mL/
kg) and intraperitoneal xylazine (13 mg/mL/kg), and placed in a
stereotaxic apparatus (Kopf Instruments, Tujunga, CA, USA). The
skull was exposed, and two small burr holes were drilled at the
following coordinates relative to bregma: anterior–posterior,
+2.9 mm; medial–lateral,  0.6 mm. A 5-lL Hamilton Syringe
(Hamilton, Reno, NV, USA) was used to bilaterally infuse
ibotenic acid (2% in 0.1 M PBS; Sigma-Aldrich) or vehicle at two
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dorsal–ventral coordinates corresponding to the IL and PL regions
of the mPFC (from the top of skull, 5.0 and 2.5 mm; 0.25 lL
per 1 min per injection). The needle was left in place for 3 min
following each injection, to allow for adequate diffusion. Rats
were allowed 2 weeks to recover from surgery prior to tissue
collection.
Sham-lesioned and mPFC-lesioned rats were perfused at two dif-
ferent time points, ZT10 and ZT18, corresponding, respectively, to
nadirs and peaks in cFos immunoreactivity. One series of brain
sections containing the NAc core and shell and the rostral and mid-
dle VTA from all sham-operated and lesioned rats were processed
simultaneously for cFos immunoreactivity, and analysed as
described above. The location and size of the lesions were deter-
mined by examining the area in cFos-immunostained mPFC sections
showing tissue damage and lack of staining. Lesions of the mPFC
typically spanned a distance from anterior to posterior of +4.85 mm
to +1.70 mm relative to bregma, and encompassed the entire IL
region and the majority of the PL region (ZT10, n = 6; ZT18,
n = 8). Sham-operated rats did not have any damage (ZT10, n = 6;
ZT18, n = 4).
Statistical analysis
Two-way ANOVAs followed by Bonferroni comparisons or indepen-
dent t-tests were used to assess lesion and time-of-day effects.
Results
Rhythmic neural activation in the mesolimbic reward system
A signiﬁcant diurnal rhythm in the number of cFos-IR cells was
observed in the NAc core (ANOVA, K5 = 22.99, P = 0.0003; CIRC-
WAVE, F4,35 = 10.11, P < 0.0001) and shell (ANOVA, K5 = 27.57,
P < 0.0001; CIRCWAVE, F4,35 = 10.54, P < 0.0001; Figs 2C and D
and 3), in all three subregions of the mPFC [ACA (ANOVA,
K5 = 20.73, P = 0.0009; CIRCWAVE, F4,38 = 8.87, P < 0.0001), PL
(ANOVA, K5 = 18.78, P = 0.0021; CIRCWAVE, F4,38 = 7.19,
P = 0.0002), and IL (ANOVA, K5 = 13.70, P = 0.0177; CIRCWAVE,
F2,40 = 3.29, P = 0.048); Figs 2A and B and 4], and in the VTA
(ANOVA, K5 = 23.99, P = 0.0002; CIRCWAVE, F2,33 = 22.56,
P < 0.0001; Figs 2E and F and 5A). In general, rhythms in the
NAc, mPFC and VTA were similar in phase, with peaks during the
night and nadirs during the late day. In the NAc core and shell,
cFos expression had a nadir at ZT6–10 and peaks at ZT18–22
(Fig. 3). Within the subregions of the mPFC, cFos expression had a
nadir at ZT10 (ACA and IL region) or ZT6-10 (PL region) and a
peak at ZT18 (IL and PL regions) or ZT14–18 (ACA; Fig. 4). In
the VTA, cFos expression had a nadir at ZT10 and peaks at ZT18–
22 (Fig. 5A).
The number of VTA TH-IR cells co-expressing cFos also
showed a diurnal rhythm (ANOVA, F5,30 = 34.27, P < 0.001; CIRC-
WAVE, F4,31 = 28.82, P < 0.0001; Figs 2E and F and 5C), with a
nadir at ZT10 and peaks at ZT18–22. Moreover, at the peak time
(ZT18), 18.8%  1.8% of total VTA TH-IR cells also expressed
cFos, and 23.8%  3.9% of cFos-IR cells expressed TH
(Fig. 5D). The number of TH-IR cells also varied over the day
(F5,35 = 4.68, P = 0.003), but in an ultradian fashion. Multiple
peaks were observed at ZT6, ZT14, and ZT22, and a nadir at
ZT10 (Fig. 5B).
In contrast, no diurnal rhythms in the numbers of cFos-IR cells
were observed in the BLA or the DG (Fig. 6A and C). A marginal
diurnal rhythmicity was observed in the CeA (CIRCWAVE,
F2,39 = 3.25, P = 0.049; Fig. 6B), and ANOVA failed to detect signiﬁ-
cant differences between different time points (ANOVA, F5,36 = 2.19,
P = 0.076). Finally, consistent with previous reports (Schwartz
et al., 2000), the number of SCN cFos-IR cells was signiﬁcantly
greater at ZT6 than at ZT18 (P = 0.0022; Fig. 6D).
mPFC lesions attenuate rhythmic neural activation in the NAc
without influencing the VTA
mPFC lesions altered cFos rhythms in the NAc shell and core
(Figs 7A and B and 8), but not in the VTA (Fig. 7C). In the
NAc, mPFC lesions had a signiﬁcant effect on the numbers of
cFos-IR cells in both the core (F1,19 = 22.25, P = 0.0002) and the
shell (F1,19 = 22.57, P = 0.0001). Moreover, signiﬁcant interactions
were found between time of day and lesion status for the NAc
A B
C D
E F
Fig. 1. Areas of analyses for cell counts. Schematic representations of areas
of analyses in: (A) the ACA, IL and PL regions of the mPFC; (B) the NAc
core and shell; (C) the CeA and BLA; (D) the DG; (E) the SCN; and (F) the
VTA. ac, anterior commissure; aq, cerebral aqueduct; cc, corpus callosum; fr,
fasciculus retroﬂexus; lv, lateral ventricle; ml, medial lemniscus; ot, optic
tract; sn, substantia nigra; st, stria terminalis; 3V, third ventricle. Drawings
modiﬁed from Swanson (1998).
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shell (F1,19 = 50.01, P < 0.0001) and core (F1,19 = 32.94,
P < 0.0001). Post hoc analysis revealed that mPFC lesions reduced
the number of cFos-IR cells at ZT18 (core, P = 0.0003; shell,
P < 0.0001), as compared with the sham group, and increased the
number of cFos-IR cells at ZT10 in the shell (P = 0.019), but not
in the core. Changes in the numbers of cFos-IR cells with mPFC
lesions resulted in a loss of time-of-day differences in the NAc
shell, and an attenuation of the difference in the NAc core (ZT10
vs. ZT18: P = 0.0258). In contrast to the NAc, mPFC lesions did
not affect the number of cFos-IR cells in the VTA, and a signiﬁ-
cant time of day difference was observed in lesioned rats (ZT10
vs. ZT18: P < 0.0001). Finally, sham treatment did not disrupt
A B
C D
E F
Fig. 2. cFos and TH immunoreactivity. Images showing cFos immunoreactivity (black) and TH immunoreactivity (brown) in the mPFC (prelimbic area), NAc
(core and shell) and VTA in representative animals at ZT10 (A, C, and E) and ZT18 (B, D, and F). Arrows in F indicate cells co-expressing cFos and TH.
Scale bars: 100 lm (A–D) or 50 lm (E and F). cc, corpus callosum. [Color version of ﬁgure available online].
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diurnal rhythms in cFos immunoreactivity, and signiﬁcant time-of-
day differences were detected in the NAc core (P < 0.0001), NAc
shell (P < 0.0001), and VTA (P = 0.0161), consistent with the
ﬁndings described above. These results suggest that mPFC inputs
mediate neural activation rhythms in the NAc, but not in the
VTA.
Discussion
The current study demonstrated diurnal rhythms of neural activation
in the VTA, NAc, and mPFC, which were generally elevated during
the dark phase (ZT18–ZT22), and had nadirs during the end of the
light phase (ZT10). In the VTA, this rhythm in neural activation was
observed in both dopaminergic and non-dopaminergic cells. One
major question arising from these observations concerns the origin
of the signal driving these rhythms in neural activation. As both the
NAc and the VTA receive glutamatergic inputs from the mPFC (Carr
& Sesack, 2000; Gabbott et al., 2005; Sesack & Grace, 2010), we
tested the hypothesis that mPFC inputs contribute to the observed
neural activation rhythms. Indeed, ablation of the mPFC eliminated
the diurnal rhythm in NAc cFos immunoreactivity by attenuating the
peak expression at ZT18, but did not affect rhythms in VTA activity.
A comprehensive characterisation of the daily expression of cFos
in the mesocorticolimbic reward system revealed diurnal rhythms,
with peaks during the middle–end of the dark phase and nadirs dur-
ing the end of the light phase, in the NAc, VTA, and mPFC, but
not in the BLA or DG. Marginal rhythmicity was detected in the
CeA. Although the expression of cFos is a useful indicator of
neuronal activation, it is not always synonymous with membrane
depolarisation, as dissociations have been observed between in vivo
single-unit recordings and expression of cFos (Hoffman & Lyo,
2002). Nonetheless, previous studies have also utilised cFos as a
A
B
Fig. 3. Diurnal rhythms in cFos expression in the NAc: numbers of cFos-IR
cells in the NAc core (A) and shell (B). Data are expressed as means  SE
of the mean. The statistical relationship between the groups is indicated by
lower-case letters; groups that share a common letter do not differ signiﬁ-
cantly.
A
B
C
Fig. 4. Diurnal rhythms in cFos expression in the mPFC: numbers of cFos-
IR cells in the ACA (A), IL region (B), and PL region (C) of the mPFC.
Data are expressed as means  SE of the mean. The statistical relationship
between the groups is indicated by lower-case letters; groups that share a
common letter do not differ signiﬁcantly.
A B
C D
Fig. 5. Diurnal rhythms in cFos expression by dopaminergic and non-dopa-
minergic neurons in the VTA: diurnal variation in the numbers of cFos-IR
cells (A), TH-IR cells (B), and dual cFos/TH-IR cells (C), and the percentage
of TH cells co-expressing cFos (D), in the VTA. Data are expressed as mean
number  SE of the mean. The statistical relationship between the groups is
indicated by lower-case letters; groups that share a common letter do not dif-
fer signiﬁcantly.
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marker for daily changes in neural activation; however, these
included only a few time points, or were limited to a particular
portion of the day. Overall, the phases of these rhythms were con-
sistent with our own observations. Speciﬁcally, a qualitative investi-
gation of cFos protein expression during sleep and awake states
reported peak cFos immunoreactivity at ZT18 (dark phase) as com-
pared with ZT6–9 (light phase) in the frontal cortex and NAc (Pom-
peiano et al., 1994). Additionally, data from studies of food
anticipatory behavior also showed rhythms in cFos immunoreactivity
in the NAc and PFC, over a period of several hours (Angeles-Cas-
tellanos et al., 2007; Verwey et al., 2007). The absence of rhythms
in neural activation in the DG and BLA under basal conditions
suggests that these regions may not be involved in mediating
rhythms in reward. However, there is evidence to support their role
as accessory regions that are sensitive to the timing of rewards in
the environment. Salient stimuli, such as palatable food and
restricted feeding schedules, alter patterns of neural activation and
clock gene expression throughout the reward system (Mendoza
et al., 2005), and can generate rhythmicity in the DG and amygdala
(Verwey et al., 2007). As these regions project to the mPFC, NAc, and
VTA (Kelley, 2004), under these conditions they may convey timing
information throughout the reward system and to other brain areas.
The mPFC, NAc and VTA are tightly interconnected, and form a
major component of the neural circuits involved in motivation and
reward (Kelley & Berridge, 2002; Hyman et al., 2006). The ﬁnding
that rhythms in neural activation are similar within this network
forms the basis for several hypotheses regarding the generation of
these activity rhythms. First, it is possible that glutamatergic and
dopaminergic interconnections originating from the mPFC and VTA
(Stuber et al., 2012) modulate the activity within this network.
Indeed, a main ﬁnding of the current study is that mPFC inputs con-
tribute to the diurnal rhythms in neural activation in the NAc, sug-
gesting that these rhythms are inﬂuenced by glutamatergic mPFC
outputs. These ﬁndings are consistent with previous reports of circa-
dian rhythms in glutamate in the NAc or striatal dialysate (Marquez
de Prado et al., 2000; Castaneda et al., 2004), with peaks around
ZT18 and nadirs throughout the mid-light phase.
A B
C D
Fig. 6. Diurnal variation in neural activation in the amygdala, hippocampus
and SCN: numbers of cFos-IR in the BLA (A), the CeA (B), the DG (C),
and the SCN (D). Data are expressed as mean  SE of the mean. *Signiﬁ-
cant differences between time points.
A
B
C
Fig. 7. The mPFC modulates neural activation in the mesolimbic reward
system: effects of sham surgery and mPFC lesions on cFos immunoreactivity
in the NAc core (A), NAc shell (B), and VTA (C). Data are expressed as
mean  SE of the mean. *Signiﬁcant effect of time of day within the treat-
ment group. #Signiﬁcant lesion effect within the time of day.
A B C
D
Fig. 8. cFos immunoreactivity in mPFC-lesioned brains: images showing
the mPFC in representative sham (A) and lesioned (B) rats, in brain sections
immunoprocessed for cFos immunoreactivity. Arrows in B indicate the extent
of the lesion site encompassing the PL and IL regions, with sparing of the
ACA. The images in C and D illustrate cFos immunoreactivity in the NAc
shell at ZT18 in sham (C) and lesioned (D) rats. Scale bars: 250 lm (A and
B) or 100 lm (C and D). cc, corpus callosum.
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Conversely, VTA rhythms were not dependent on mPFC inputs.
Therefore, an alternative hypothesis is that rhythms in activation of
VTA, mPFC and, potentially, NAc neurons instead derive from
inputs from other brain areas, including the master circadian clock,
the SCN, in the hypothalamus. The VTA is positioned to receive
timing information from the SCN via two indirect circuits: one
through the medial preoptic nucleus (Luo & Aston-Jones, 2009),
and the other by way of orexinergic neurons in the hypothalamus
(Korotkova et al., 2003; Deurveilher & Semba, 2005; Yoshida
et al., 2006). There is currently little evidence to support a func-
tional role of the former pathway, whereas the latter pathway
appears to be ideally positioned to convey circadian information to
the reward system. A large number of orexinergic efferents contact
the VTA (Fadel & Deutch, 2002), and, in addition to its familiar
role in arousal and wakefulness (Sakurai, 2007), the orexin system
has been implicated in the regulation of reward and addiction (Har-
ris et al., 2005; Aston-Jones et al., 2009) via its role in mediating
reward-induced activation of VTA dopaminergic neurons (Borgland
et al., 2006; Zheng et al., 2007). The inﬂuence of orexinergic inputs
on VTA dopamine activity ﬂuctuates over the course of the day,
with greater activation during the dark phase (Moorman & Aston-
Jones, 2010). Moreover, orexin neurons receive direct inputs from
the SCN (Cutler et al., 1999; McGranaghan & Piggins, 2001). Per-
turbations in SCN activity with phase shifting or SCN ablation alter
(Akiyama et al., 2004; Zhang et al., 2004; Marston et al., 2008) the
normal diurnal rhythms of orexin activation and signaling (Esta-
brooke et al., 2001; Lee et al., 2005). Interestingly, clock gene
expression in forebrain regions is attenuated in mice lacking orexin
neurons (Akiyama et al., 2004). Together, these ﬁndings suggest an
integrated functional relationship between the circadian, orexigenic
and reward systems.
Moorman & Aston-Jones (2010) recently showed that the activity
of VTA dopaminergic neurons during the dark phase is regulated by
the mPFC and orexinergic afferents, with a gating role of orexin in
enhancing mPFC excitatory control over dopaminergic neurons.
Glutamatergic projections from the mPFC reach both dopaminergic
and non-dopaminergic neurons of the VTA (Rossetti et al., 1998;
Omelchenko & Sesack, 2007). Modulation of corticolimbic glutama-
tergic inputs by orexin has been suggested to occur via increased N-
methyl-D-aspartate receptor trafﬁcking (Borgland et al., 2006) and
via orexin receptor-mediated changes in phosphoinositol signaling
(Moorman & Aston-Jones, 2010). In the current study, we did not
observe an effect of mPFC lesions on peak expression of VTA neu-
ral activity, suggesting that mPFC inputs did not make a major con-
tribution to baseline excitation. However, it is possible that orexin
inputs in mPFC-lesioned animals are sufﬁcient to maintain the VTA
activity rhythms.
We hypothesised that the observed rhythms in neural activation in
the NAc and mPFC were, in part, mediated by dopamine originating
from the VTA. Indeed, a diurnal pattern of activated dopaminergic
cells was evident in the VTA, consistent with the neural activation
rhythms observed in the NAc and mPFC. Dopaminergic afferents to
the mPFC primarily originate from the VTA (Kelley & Berridge,
2002; Sesack & Grace, 2010), and may be responsible for convey-
ing timing information to the mPFC, and thus indirectly to the NAc.
A signiﬁcant time-of-day effect has been previously reported in
mPFC dopamine clearance, a measure of synaptic dopamine (Sleip-
ness et al., 2008). The rhythm in PFC dopamine clearance is consis-
tent with the pattern in VTA dopaminergic activity (Webb et al.,
2009), with a peak at ZT4 and a nadir at ZT12. However, the dopa-
mine clearance rhythm does not match the rhythm in cFos activity,
and thus may not be causing the rhythms in neural activation. In
addition, a subportion of the rhythmic cFos immunoreactivity in the
VTA neurons may be glutamatergic. Luo et al. (2008) have reported
that VTA neurons that ﬁre selectively during the active night phase
express mRNA for the glutamate cell marker vesicular glutamate
transporter 2, and account for 14% of all active cells during the dark
phase. Moreover, a subset of dopaminergic neurons also synthesise
glutamate and release it into the NAc (Tecuapetla et al., 2010).
These ﬁndings suggest that VTA neural activation may contribute to
rhythms in the NAc and mPFC, via release of glutamate and/or
dopamine.
A ﬁnal hypothesis for the generation of neural activation
rhythms in the mPFC, VTA and NAc is that these originate from
oscillations in core circadian clock genes. Clock genes have been
localised to many reward-related brain areas (McClung et al.,
2005; Angeles-Castellanos et al., 2007; Verwey et al., 2007; Webb
et al., 2009; Ramanathan et al., 2010), and oscillate in the NAc
and mPFC (Angeles-Castellanos et al., 2007), but do not appear to
be rhythmically expressed in the VTA (Webb et al., 2009). It is
clear that clock genes play a role in regulating reward, as clock
gene disruptions alter typical behavioral responses to drugs of
abuse. For instance, period1 knockout mice show increased
cocaine conditioned place preference (Abarca et al., 2002); intra-
cerebroventricular injections of a DNAzyme that interferes with
Period1 impairs morphine conditioned place preference (Liu et al.,
2005); period2 mutant mice show increased alcohol consumption
(Brager et al., 2011); and mice lacking a functional clock gene are
hypersensitive to cocaine (McClung et al., 2005). Clock gene dis-
ruptions also affect the normal functioning of the reward system.
For instance, clock gene knockout mice have increased excitability
of dopamine neurons and increased TH expression in the VTA
(McClung et al., 2005); Period2 knockout mice show altered dopa-
mine activity, with decreased transcription of the monoamine oxi-
dase gene throughout the mesolimbic dopamine system, increased
extracellular levels of dopamine, and altered neural activity in the
striatum (Hampp et al., 2008); VTA-speciﬁc knockdown of clock
genes in mice results in increased dopamine cell ﬁring and altered
expression of genes associated with reward, such as increased
expression of the genes encoding TH, dopamine receptor, and
Homer2, and decreased expression of the genes encoding ionotrop-
ic glutamate receptor subunit 2 and dopamine b-hydroxylase (Muk-
herjee et al., 2010). The necessity of mesolimbic clock gene
oscillations for rhythms in reward-related behaviors remains to be
determined.
In summary, the current study demonstrates diurnal rhythms in
neural activation in areas within the mesolimbic pathway, with a
causal role for mPFC outputs in the generation of such rhythms in
the NAc. These neural activation rhythms, in turn, may regulate
diurnal differences in reward behaviors. The nadir in cFos immuno-
reactivity during the late light phase coincides with a nadir in the
expression of psychostimulant reward (Roberts & Andrews, 1997;
Baird & Gauvin, 2000; Roberts et al., 2002; Webb et al., 2009),
whereas the peak in cFos expression correlates with high expression
of reward for sexual behaviors (Webb et al., 2009). Future studies
will be needed to determine whether these neural activation rhythms
are, indeed, critical for rhythmic reward behavior.
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